Scinovex
articleTop 10% cited

Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy

Gynecologic Oncology · 2009 · Vol. 116(1) · pp. 92–98
Leigh A. CantrellChunxiao ZhouAlberto A. MendivilKimberly MalloyPaola A. GehrigVictoria Bae‐Jump
Metabolism, Diabetes, and CancerPI3K/AKT/mTOR signaling in cancerCancer, Hypoxia, and MetabolismMedicineMetforminEndometrial cancerOncologyCancer researchInternal medicineCell growthCancerGynecologyInsulin

MeSH terms

Cell CycleDose-Response Relationship, DrugFemaleHumansMetforminProtein KinasesRNA, MessengerSignal TransductionEndometrial NeoplasmsApoptosisTelomeraseReverse Transcriptase Polymerase Chain ReactionCell Line, TumorCell Growth ProcessesTOR Serine-Threonine Kinases

Funding

  • V Foundation for Cancer Research
  • National Institutes of Health
  • National Center for Research Resources
Citations
329
FWCI
7.66
field-weighted impact
References
47
Percentile
98%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.